Login Register Cart 0
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Antioxidant and Antibacterial Activity of Sulfonamides Derived from Carvacrol: A Structure-Activity Relationship Study

Author(s): Aldo S. de Oliveira*, Luiz F. S. de Souza, Ricardo J. Nunes, Susana Johann, David L. Palomino-Salcedo, Leonardo L.G. Ferreira and Adriano D. Andricopulo

Volume 20, Issue 3, 2020

Page: [173 - 181] Pages: 9

DOI: 10.2174/1568026619666191127144336

Price: $65

Abstract

Background: Bacterial resistance to antibiotics is a growing problem in all countries and has been discussed worldwide. In this sense, the development of new drugs with antibiotic properties is highly desirable in the context of medicinal chemistry.

Methodology: In this paper we investigate the antioxidant and antibacterial potential of sulfonamides derived from carvacrol, a small molecule with drug-like properties. Most sulfonamides had antioxidant and antibacterial potential, especially compound S-6, derived from beta-naphthylamine.

Results: To understand the possible mechanisms of action involved in biological activity, the experimental results were compared with molecular docking data.

Conclusion: This research allows appropriate discussion on the identified structure activity relationships.

Keywords: Carvacrol, Sulfonamides, Bacterial resistance, S. aureus, E. coli, Antioxidant.

« Previous Next »
Graphical Abstract

[1]
Yewale, V.N. Antimicrobial resistance — A ticking bomb. Indian Pediatr., 2014, 51(3), 171-172.
[http://dx.doi.org/10.1007/s13312-014-0374-3]
[2]
Nolte, O. Antimicrobial resistance in the 21st century: a multifaceted challenge. Protein Pept. Lett., 2014, 21(4), 330-335.
[http://dx.doi.org/10.2174/09298665113206660106] [PMID: 24164264]
[3]
Ledingham, K.; Hinchliffe, S.; Jackson, M.; Thomas, F.; Tomson, G. Antibiotic resistance: using a cultural contexts of health approach to address a global health challenge. World Heal. Organ., 2019.
[4]
Yelin, I.; Kishony, R. Antibiotic resistance. Cell, 2018, 172(5), 1136-1136.e1.
[http://dx.doi.org/10.1016/j.cell.2018.02.018] [PMID: 29474914]
[5]
Spellberg, B.; Bartlett, J.G.; Gilbert, D.N. The future of antibiotics and resistance. N. Engl. J. Med., 2013, 368(4), 299-302.
[http://dx.doi.org/10.1056/NEJMp1215093] [PMID: 23343059]
[6]
Friedman, N.D.; Temkin, E.; Carmeli, Y. The negative impact of antibiotic resistance. Clin. Microbiol. Infect., 2016, 22(5), 416-422.
[http://dx.doi.org/10.1016/j.cmi.2015.12.002] [PMID: 26706614]
[7]
Alemkere, G.; Tenna, A.; Engidawork, E. Antibiotic use practice and predictors of hospital outcome among patients with systemic bacterial infection: Identifying targets for antibiotic and health care resource stewardship. PLoS One, 2019, 14(2) e0212661
[http://dx.doi.org/10.1371/journal.pone.0212661] [PMID: 30794660]
[8]
Costa, J.M.D.; Moura, C.S.; Pádua, C.A.M.; Vegi, A.S.F.; Magalhães, S.M.S.; Rodrigues, M.B.; Ribeiro, A.Q. Restrictive measure for the commercialization of antimicrobials in Brazil: results achieved. Rev. Saude Publica, 2019, 53, 68.
[http://dx.doi.org/10.11606/s1518-8787.2019053000879] [PMID: 31432930]
[9]
Domingues, P.H.F.; Galvão, T.F.; de Andrade, K.R.C.; Araújo, P.C.; Silva, M.T.; Pereira, M.G. Prevalence and factors associated with self-medication in adults in the Federal District: a populationbased cross-sectional study. Epidemiol. Serv. Health, 2017, 26(2), 319-330.
[http://dx.doi.org/10.5123/S1679-49742017000200009]
[10]
Jeśman, C.; Młudzik, A.; Cybulska, M. History of antibiotics and sulphonamides discoveries. Pol; Merkur. Lekarski, 2011, 30(179), 320-322.
[PMID: 21675132]
[11]
Wainwright, M. The first miracle drugs: how the sulfa drugs transformed medicine. Perspect. Biol. Med., 2007, 50(4), 639-642.
[http://dx.doi.org/10.1353/pbm.2007.0057]
[12]
van Alphen, L.B.; Burt, S.A.; Veenendaal, A.K.J.; Bleumink-Pluym, N.M.C.; van Putten, J.P.M. The natural antimicrobial carvacrol inhibits Campylobacter jejuni motility and infection of epithelial cells. PLoS One, 2012, 7(9) e45343
[http://dx.doi.org/10.1371/journal.pone.0045343] [PMID: 23049787]
[13]
de Oliveira, A.S.; Llanes, L.C.; Brighente, I.M.C.; Nunes, R.J.; Yunes, R.A.; Máximo, N. Junior; Baumgart, A.M.K.; Aust, A.N.; Cruz, A.B. New sulfonamides derived from carvacrol: compounds with high antibacterial activity against resistant staphylococcus aureus Strains. J. Biosci. Med., 2016, 4(07), 105-114.
[http://dx.doi.org/10.4236/jbm.2016.47011]
[14]
Alam, M.N.; Bristi, N.J.; Rafiquzzaman, M. Review on in vivo and in vitro methods evaluation of antioxidant activity. Saudi Pharm. J., 2013, 21(2), 143-152.
[http://dx.doi.org/10.1016/j.jsps.2012.05.002] [PMID: 24936134]
[15]
Souza, M.A.; Johann, S.; Lima, L.A.; Campos, F.F.; Mendes, I.C.; Beraldo, H.; Souza-Fagundes, E.M.; Cisalpino, P.S.; Rosa, C.A.; Alves, T.M.; de Sá, N.P.; Zani, C.L. The antimicrobial activity of lapachol and its thiosemicarbazone and semicarbazone derivatives. Mem. Inst. Oswaldo Cruz, 2013, 108(3)
[http://dx.doi.org/10.1590/S0074-02762013000300013] [PMID: 23778660]
[16]
Schrödinger Release; Canvas. Schrödinger. LLC: New York, 2016.
[17]
Schrödinger Release; LigPrep: Schrödinger. LLC: New York, 2016.
[18]
Shelley, J.C.; Cholleti, A.; Frye, L.L.; Greenwood, J.R.; Timlin, M.R.; Uchimaya, M. Epik: a software program for pK(a) prediction and protonation state generation for drug-like molecules. J. Comput. Aided Mol. Des., 2007, 21(12), 681-691.
[http://dx.doi.org/10.1007/s10822-007-9133-z] [PMID: 17899391]
[19]
Harder, E.; Damm, W.; Maple, J.; Wu, C.; Reboul, M.; Xiang, J.Y.; Wang, L.; Lupyan, D.; Dahlgren, M.K.; Knight, J.L.; Kaus, J.W.; Cerutti, D.S.; Krilov, G.; Jorgensen, W.L.; Abel, R.; Friesner, R.A. OPLS3: A force field providing broad coverage of drug-like small molecules and Proteins. J. Chem. Theory Comput., 2016, 12(1), 281-296.
[http://dx.doi.org/10.1021/acs.jctc.5b00864] [PMID: 26584231]
[20]
Rostkowski, M.; Olsson, M.H.; Søndergaard, C.R.; Jensen, J.H. Graphical analysis of pH-dependent properties of proteins predicted using PROPKA. BMC Struct. Biol., 2011, 11, 6.
[http://dx.doi.org/10.1186/1472-6807-11-6] [PMID: 21269479]
[21]
Jones, G.; Willett, P.; Glen, R.C.; Leach, A.R.; Taylor, R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol., 1997, 267(3), 727-748.
[http://dx.doi.org/10.1006/jmbi.1996.0897] [PMID: 9126849]
[22]
Korb, O.; Stützle, T.; Exner, T.E. Empirical scoring functions for advanced protein-ligand docking with PLANTS. J. Chem. Inf. Model., 2009, 49(1), 84-96.
[http://dx.doi.org/10.1021/ci800298z] [PMID: 19125657]
[23]
Nageswari, G.; George, G.; Ramalingam, S.; Govindarajan, M. Electronic and vibrational spectroscopic (FT-IR and FT-Raman) investigation using ab initio (HF) and DFT (B3LYP and B3PW91) and HOMO/LUMO/MEP analysis on the structure of l-serine methyl ester hydrogen chloride. J. Mol. Struct., 2018, 1166, 422-441.
[http://dx.doi.org/10.1016/j.molstruc.2018.04.014]
[24]
Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A. Gaussian 09, Revision B.01; Gaussian, Inc.: Wallingford, CT, 2009.
[25]
Ribeiro da Cunha, B.; Fonseca, L.P.; Calado, C.R.C. Antibiotic Discovery: Where have we come from, where do we go? Antibiotics (Basel), 2019, 8(2) E45
[http://dx.doi.org/10.3390/antibiotics8020045] [PMID: 31022923]
[26]
Brunton, L.L.; Chabner, B.A.; Knollmann, B.C. Goodman & Gilman's the pharmacological basis of therapeutics AMGH Group Publisher: Porto Alegrem. 2012.
[27]
Deep, A.; Jain, S.; Sharma, P.C.; Verma, P.; Kumar, M.; Dora, C.P. Design and biological evaluation of biphenyl-4-carboxylic acid hydrazide-hydrazone for antimicrobial activity. Acta Pol. Pharm., 2010, 67(3), 255-259.
[PMID: 20524427]
[28]
Rollas, S.; Küçükgüzel, Ş.G. Biological activities of hydrazone derivatives. Molecules, 2007, 12(8), 1910-1939.
[http://dx.doi.org/10.3390/12081910] [PMID: 17960096]
[29]
Lee, S.Y. Systems Biology and Biotechnology of Escherichia coli.Lee, Sang Yup. Springer: Berlin, 2009.
[http://dx.doi.org/10.1007/978-1-4020-9394-4]
[30]
Tenaillon, O.; Skurnik, D.; Picard, B.; Denamur, E. The population genetics of commensal Escherichia coli. Nat. Rev. Microbiol., 2010, 8(3), 207-217.
[http://dx.doi.org/10.1038/nrmicro2298] [PMID: 20157339]
[31]
Chun, S.S.; Vattem, D.A.; Lin, Y.T.; Shetty, K. Phenolic antioxidants from clonal oregano (origanum vulgare) with antimicrobial activity against helicobacter pylori. Process Biochem., 2005, 40(2), 809-816.
[http://dx.doi.org/10.1016/j.procbio.2004.02.018]
[32]
Wang, J.; Hu, S.; Nie, S.; Yu, Q.; Xie, M. Reviews on mechanisms of in vitro antioxidant activity of polysaccharides. Oxid. Med. Cell. Longev., 2016, 2016 5692852
[http://dx.doi.org/10.1155/2016/5692852] [PMID: 26682009]
[33]
Denardin, C.C.; Hirsch, G.E.; da Rocha, R.F.; Vizzotto, M.; Henriques, A.T.; Moreira, J.C.F.; Guma, F.T.C.R.; Emanuelli, T. Antioxidant capacity and bioactive compounds of four Brazilian native fruits. Yao Wu Shi Pin Fen Xi, 2015, 23(3), 387-398.
[http://dx.doi.org/10.1016/j.jfda.2015.01.006] [PMID: 28911695]
[34]
Ferreira, A.L.A.; Matsubara, L.S. Free radicals: concepts, related diseases, defense system and oxidative stress. Rev. Assoc. Med. Bras., 1997, 43(1), 61-68.
[http://dx.doi.org/10.1590/S0104-42301997000100014] [PMID: 9224995]
[35]
Arnr, C.; Rhm, M. VPD Thiago Brasileiro de Vasconcelos, B.; Richelly Nunes Rocha Cardoso, A.; Batista Josino, J.; Hermelinda Maia Macena, R. Free radicals and antioxidants: protection or danger? Ciênc. Biol. Saúde, 2014, 16(3)
[http://dx.doi.org/10.17921/2447-8938.2014v16n3p%25p]

Rights & Permissions Print Cite
Article Metrics
22
World Chagas Disease
© 2024 Bentham Science Publishers | Privacy Policy